Kunst, N., Wang, S., Hood, A., Mougalian, S. S., DiGiovanna, M. P., Adelson, K., & Pusztai, L. (2020). Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)–Positive Breast Cancer. JAMA Netw Open.
Chicago Style CitationKunst, Natalia, Shi-Yi Wang, Annette Hood, Sarah S. Mougalian, Michael P. DiGiovanna, Kerin Adelson, i Lajos Pusztai. "Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)–Positive Breast Cancer." JAMA Netw Open 2020.
Cita MLAKunst, Natalia, et al. "Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)–Positive Breast Cancer." JAMA Netw Open 2020.
Atenció: Aquestes cites poden no estar 100% correctes.